Pulmonary arterial hypertension
MONDO:0015924Pulmonary arterial hypertension (PAH) is a group of diseases characterized by mean pulmonary artery pressure >20 mmHg and elevated pulmonary arterial resistance leading to right heart failure. PAH is progressive and potentially fatal. PAH may be idiopathic and/ or familial, have overt features of venous/capillary involvement (pulmonary veno-occlusive disease, PVOD/pulmonary capillary hemangiomatosis, PCH), induced by drug or toxin (drug-or toxin-induced PAH), or associated with other diseases like congenital heart disease, connective tissue disease, HIV, schistosomiasis, portal hypertension (PAH associated with other disease).
Also known as: PAH, pulmonary arterial hypertension, PAH with overt features of venous/capillaries involvement, PVOD/PCH, PPH, idiopathic pulmonary hypertension
323 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New hope for PAH patients? india study tests sotatercept safety
Disease control Not yet recruitingThis study tests the safety of a new medicine called sotatercept for adults in India with pulmonary arterial hypertension (PAH), a condition where blood vessels in the lungs become narrow, making breathing hard. About 30 people will receive sotatercept along with their usual trea…
Phase: PHASE4 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Which drug is best for pulmonary hypertensive crisis? new trial aims to find out
Disease control Not yet recruitingThis trial will compare three drugs—dopamine, norepinephrine, and epinephrine—to see which works best for people experiencing a pulmonary hypertensive crisis, a life-threatening spike in blood pressure in the lungs. The study will enroll 75 adults with pulmonary arterial hyperten…
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Lung patients may soon do rehab from home via app
Disease control Not yet recruitingThis study tests whether a 12-week tele-pulmonary rehabilitation program, done at home via an app with a physiotherapist, helps people with chronic lung diseases start and stick with rehab better than going to a center. 90 patients will be randomly assigned to either remote rehab…
Phase: NA • Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a simple supplement ease a rare lung disease?
Disease control Not yet recruitingThis phase 2 trial tests a dietary supplement called 2-HOBA in 12 adults with pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lungs strains the heart. Participants take the supplement three times daily for 12 weeks. The study checks if 2-HOBA i…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug hopes to ease rare lung condition in children
Disease control Not yet recruitingThis study tests the safety and tolerability of sotatercept in Japanese children aged 1 to 18 with pulmonary arterial hypertension (PAH), a condition where blood vessels in the lungs narrow, making the heart work harder. Participants receive sotatercept injections every three wee…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New PAH drug IKT-001 moves to Long-Term safety check
Disease control Not yet recruitingThis study is checking the long-term safety of a daily pill called IKT-001 for people with pulmonary arterial hypertension (PAH), a serious lung condition. About 484 adults who have already completed an earlier IKT-001 study will take the drug for an extended period. Researchers …
Phase: PHASE3 • Sponsor: Inhibikase Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for PAH patients: Extended-Release tacrolimus enters phase 3 trial
Disease control Not yet recruitingThis Phase 3 study tests VI-0106, an extended-release form of tacrolimus, in 300 people with pulmonary arterial hypertension (PAH) who still have trouble with daily activities despite taking standard PAH medications. Participants will receive either the drug or a placebo for 24 w…
Phase: PHASE3 • Sponsor: VIVUS LLC • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a daily shot help control rare lung disease?
Disease control Not yet recruitingThis phase 2 trial tests whether adding tiprelestat (elafin) to standard care improves blood flow in the lungs for people with pulmonary arterial hypertension (PAH). About 90 adults with moderate to severe PAH will receive either a daily injection of tiprelestat or a placebo for …
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New program aims to protect hearts of breast cancer survivors
Disease control Not yet recruitingThis small pilot study will test a program where nurses and general practitioners help breast cancer survivors who also have heart disease make healthy lifestyle changes. The program includes exercise, diet changes, quitting smoking, and stress-reducing activities like yoga. The …
Phase: NA • Sponsor: University of Southern Queensland • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug may shield heart surgery patients from deadly complications
Disease control Not yet recruitingThis study tests whether the drug vericiguat can prevent serious heart and organ problems in people undergoing heart surgery. About 600 high-risk patients will receive either vericiguat plus standard care or standard care alone. The goal is to see if vericiguat reduces early comp…
Phase: NA • Sponsor: Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New stitch and glue combo aims to cut infections after bypass surgery
Disease control Not yet recruitingThis study tests a new method for closing the breastbone after coronary artery bypass graft (CABG) surgery using special knotless barbed sutures and a skin adhesive. Researchers will compare 401 adults who receive this new closure to past patients who had standard closure. The go…
Phase: PHASE4 • Sponsor: Unity Health Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug hopes to ease rare Heart-Lung condition
Disease control Not yet recruitingThis study tests a drug called sotatercept in 40 adults with congenital heart disease and Eisenmenger syndrome, a serious condition where blood flow in the lungs is blocked. The drug is given as a shot every three weeks for 24 weeks. The goal is to see if it safely lowers pressur…
Phase: PHASE2 • Sponsor: Philipps University Marburg • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Experimental drug aims to heal damaged lung arteries
Disease control Not yet recruitingThis study will test whether the drug sotatercept can reverse damage to the lung's blood vessels in people with pulmonary arterial hypertension (PAH). Researchers will use special imaging techniques to look inside the arteries and see if they become healthier over 9 months. The s…
Sponsor: Franz Rischard, DO • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New study eyes selexipag for neglected form of lung hypertension
Disease control Not yet recruitingThis study looks at how well the oral medication selexipag works over the long term for people with a specific type of lung hypertension caused by schistosomiasis (a parasitic infection). Researchers will compare patients who received selexipag as part of routine care to similar …
Sponsor: Caio Júlio César dos Santos Fernandes • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New pill could ease rare lung disease
Disease control Not yet recruitingThis Phase 2 trial tests an oral drug called NS-863 in 135 adults with pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lungs makes it hard to breathe. Participants will receive either a low dose, high dose, or placebo for 24 weeks. The main goa…
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Specialist dream team takes on heart disease and diabetes
Disease control Not yet recruitingThis study tests whether a special clinic where heart, kidney, diabetes, and liver doctors work together can help people with type 2 diabetes and heart disease get better control of their blood pressure and cholesterol. About 150 adults will be randomly assigned to either usual c…
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Community exercise program aims to boost health in older adults with multiple chronic conditions
Disease control Not yet recruitingThis study tests a community-based exercise program for people aged 50 and older who have at least two chronic conditions, such as heart disease, diabetes, arthritis, or obesity. The program is designed to improve muscle strength, heart and lung fitness, and overall well-being. R…
Phase: NA • Sponsor: Associação para o Desenvolvimento do Centro Académico de Investigação e Formação Biomédica do Algarv • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could stem cells help tiniest babies breathe easier?
Disease control Not yet recruitingThis early study tests a single dose of stem cells (PNEUMOSTEM®) given into the windpipe of very premature babies with high blood pressure in their lungs. The goal is to see if it is safe and might improve breathing, reduce time on a ventilator, and lower the need for oxygen. Onl…
Phase: PHASE1 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Vitamin b trial aims to cut heart surgery risks
Disease control Not yet recruitingThis study tests whether taking vitamin B supplements before and after heart surgery can lower the chance of serious problems like heart attack, stroke, or irregular heartbeat. About 1,000 adults having heart surgery will take either vitamin B or a placebo daily for 6 months afte…
Phase: NA • Sponsor: Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can a smartwatch make virtual heart rehab work better?
Disease control Not yet recruitingThis study looks at whether a medical-grade smartwatch (CardioWatch 287-2) can improve a 13-week virtual cardiac rehab program for people with heart disease. About 216 participants will either use the watch or not, and researchers will compare their progress in areas like exercis…
Phase: NA • Sponsor: Nova Scotia Health Authority • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Triple threat: new combo therapy aims to tackle rare lung disease
Disease control Not yet recruitingThis phase 2 trial tests whether a triple combination of three drugs—sotatercept, an endothelin receptor antagonist, and a phosphodiesterase-5 inhibitor—can improve blood flow in the lungs of people newly diagnosed with pulmonary arterial hypertension (PAH). The study will enroll…
Phase: PHASE2 • Sponsor: Philipps University Marburg • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New injectable drug hopes to boost heart function in PAH patients
Disease control Not yet recruitingThis study tests whether adding an injectable medication called treprostinil to standard oral therapy can improve heart function in people with intermediate-risk pulmonary arterial hypertension (PAH). About 32 adults will receive the drug for 3 months, with heart scans and walkin…
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:35 UTC
-
Can a digital dispenser solve the pill problem for patients with multiple diseases?
Disease control Not yet recruitingThis study tests Mobili®, a portable digital dispenser that automatically gives the right pills at the right time. Researchers will enroll 96 adults with diabetes or heart disease who take at least two daily medications. Participants use the device for a period, and the study mea…
Phase: NA • Sponsor: Lusofona University • Aim: Disease control
Last updated Jun 26, 2026 17:49 UTC
-
New scan could spot hidden scarring in heart and lungs before It's too late
Diagnosis Not yet recruitingThis study tests a new radioactive tracer called 18F-FAPI-74 that may help detect scar tissue (fibrosis) in the heart and lungs earlier than current methods. Researchers will compare this new PET/CT scan to standard imaging in 210 adults with conditions like lung disease or heart…
Phase: PHASE3 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
Healing sounds and virtual worlds may replace sedatives in heart cath labs
Symptom relief Not yet recruitingThis pilot study explores whether non-drug strategies like virtual reality or relaxing soundscapes can reduce anxiety and pain in adults undergoing scheduled coronary angiography or angioplasty. Participants will be assigned to listen to calming sounds, experience a virtual reali…
Phase: NA • Sponsor: Olivier F. Bertrand • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Sound waves for better sleep: new trial tests ultrasound on heart patients
Symptom relief Not yet recruitingThis study tests whether low-intensity focused ultrasound (LIFU) applied to a nerve cluster in the neck can improve sleep quality and heart rate control in people recovering from heart surgery. 200 participants will receive either real or sham ultrasound daily for 3-7 days after …
Phase: NA • Sponsor: Renmin Hospital of Wuhan University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Can a daily supplement calm your mind and heart?
Symptom relief Not yet recruitingThis study looks at whether a supplement called Neurofast® can help people who have both anxiety and heart problems. 80 adults aged 18-70 will take the supplement or no extra treatment for 12 weeks. Researchers will measure changes in anxiety, heart rate, and blood pressure.
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
PAH patients may ditch frequent inhalers for a Once-Daily pill
Symptom relief Not yet recruitingThis study follows 32 adults with pulmonary arterial hypertension (PAH) whose doctors decide to switch them from inhaled iloprost (taken several times a day) to oral selexipag (a pill). Researchers will use questionnaires to see if the switch improves quality of life, treatment s…
Sponsor: University of Sao Paulo General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Meditation boosts heart rehab: new study tests 15-Minute mindfulness fix
Symptom relief Not yet recruitingThis study tests whether adding a short, guided mindfulness meditation session to standard cardiac rehabilitation can help heart patients feel better and control their blood pressure. Eighty adults with heart disease will be split into two groups: one gets standard rehab plus med…
Phase: NA • Sponsor: Instituto Dante Pazzanese de Cardiologia • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Can cannabis replace opioids for pain? new study aims to find out
Symptom relief Not yet recruitingThis study will compare cannabis, opioids, and two non-drug therapies (MIRE and TENS) in 1,000 people with chronic pain or circulatory disorders. The goal is to find safer, less addictive pain relief options. Researchers will measure changes in pain and nerve function using objec…
Phase: NA • Sponsor: American Association of Sensory Electrodiagnostic Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
4D MRI scans could reveal hidden clues about heart disease and cancer
Knowledge-focused Not yet recruitingThis study uses advanced 4D MRI scans to measure blood flow and heart function in adults with heart disease or cancer. Researchers aim to see if these detailed images can help predict how these diseases will progress. The study involves 1,000 participants who are already schedule…
Sponsor: Ulsan University Hospital • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Heart health advice misses the mark for ethnic minorities, study aims to find out why
Knowledge-focused Not yet recruitingThis study will interview 15 people from ethnic minority backgrounds in the UK who have heart disease. The goal is to understand their views on the diet and lifestyle advice they get from doctors, and whether it fits their cultural and religious customs. Researchers hope to learn…
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
New biorepository aims to unlock secrets of pulmonary hypertension
Knowledge-focused Not yet recruitingThis study is creating a large collection of blood samples and medical information from 1000 adults with or suspected of having pulmonary hypertension (PH). Researchers hope this resource will help them find new ways to diagnose and treat PH. Participants will provide a blood sam…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
CT scans may offer a Needle-Free way to diagnose Lung-Heart condition
Knowledge-focused Not yet recruitingThis study will look at 60 adults with a type of high blood pressure in the lungs (pre-capillary pulmonary hypertension) to see if measurements from a CT scan match those from a standard invasive heart catheter test. If the CT scan proves reliable, it could offer a safer, less in…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Which ventilator mode is best for heart patients? a pilot study aims to find out
Knowledge-focused Not yet recruitingThis study tests whether it is possible to run a larger trial comparing two ways of using a breathing machine (ventilator) in critically ill heart patients who need help breathing. The two modes are volume-controlled (delivers a set amount of air each breath) and pressure-control…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New PET scans reveal how experimental drug reshapes lung vessels in PAH
Knowledge-focused Not yet recruitingThis pilot study will use special PET/CT scans to see how the experimental drug sotatercept affects blood vessel remodeling in the lungs and heart of people with pulmonary arterial hypertension (PAH). About 15 adults with PAH will receive sotatercept and have imaging at the start…
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Heart Patients' hidden hurdles: new study probes barriers to psychosocial care
Knowledge-focused Not yet recruitingThis observational study at a French hospital will ask 20 heart rehab patients and their care teams about what stops them from getting or offering psychological and social support. The goal is to understand these barriers so that hospitals can better help patients return to work …
Sponsor: Centre Hospitalier Sud Francilien • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can mindfulness ease trauma for Justice-Involved black teens?
Knowledge-focused Not yet recruitingThis study looks at whether mindfulness-based stress reduction can help Black teenage girls who have been involved with the justice system and their parents or caregivers. About 90 participants will report on stress, PTSD symptoms, and other outcomes before and after the program.…
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New MRI shortcut could sharpen views of blood vessels
Knowledge-focused Not yet recruitingThis study aims to see if a quicker MRI scan can produce images of blood vessel walls that are just as good as the standard, longer scan. Researchers will enroll 15 adults who already need a vessel wall MRI as part of their care. The faster scan will be compared to the regular on…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Face-Down recovery after heart surgery: a simple position change that could save lives?
Knowledge-focused Not yet recruitingThis study looks at whether placing patients face-down (prone) soon after heart surgery can improve how well the right side of the heart works. The idea is that this position helps open up collapsed parts of the lungs, making it easier for the heart to pump blood. About 80 adults…
Phase: NA • Sponsor: Sahlgrenska University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New survey aims to better understand life with lung disease
Knowledge-focused Not yet recruitingThis study will create and test a new questionnaire to measure quality of life in Chinese patients with pulmonary arterial hypertension (PAH), a serious lung condition. Researchers will work with 300 adults to ensure the tool is accurate and useful for doctors and health policy. …
Sponsor: Chinese Pulmonary Vascular Disease Research Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Women-Only heart classes aim to boost recovery and knowledge
Knowledge-focused Not yet recruitingThis pilot study will test whether a women-focused education program, called Cardiac College for Women, helps women with heart disease learn more about their condition and feel better. About 50 women in cardiac rehab across Canada will either get the program plus usual care or us…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Italian study to track Real-World use of Next-Gen cholesterol drugs
Knowledge-focused Not yet recruitingThis study will look at how consistently nearly 6,000 adults in Italy take three newer cholesterol-lowering drugs (inclisiran, evolocumab, and alirocumab) over the long term. Researchers will analyze prescription records to measure adherence and persistence in everyday medical pr…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Sleep trouble linked to heart risk in lung disease patients
Knowledge-focused Not yet recruitingThis study follows 60 adults with pulmonary hypertension (high blood pressure in the lungs) for 2 years. Researchers will measure breathing problems during sleep and heart rate changes to see how they relate to the disease. No new treatment is given; participants continue their u…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Tiny study aims to unlock clues in rare lung disease
Knowledge-focused Not yet recruitingThis study looks at how changes in the cells lining blood vessels relate to lung resistance in people with pulmonary artery hypertension (PAH). Researchers will measure certain blood markers and lung pressure in 6 adults with PAH. The goal is to better understand the disease, not…
Phase: NA • Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Heart imaging revolution? 1000-Person study tests new MRI tech
Knowledge-focused Not yet recruitingThis study will test new MRI methods to find early signs of heart disease in 1000 adults. Researchers want to see if these scans can detect tiny changes in heart muscle before standard tests do. Participants will have MRI scans and blood work, but no treatment is given. The goal …
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Morning workouts may tame blood pressure in glaucoma patients
Knowledge-focused Not yet recruitingThis study looks at whether different types of exercise (like walking or strength moves) and timing (morning vs. evening) can safely lower blood pressure in people with glaucoma and high blood pressure. About 60 adults will try four exercise sessions, and their blood pressure and…
Phase: NA • Sponsor: KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Toxins in hair and urine: could they trigger rare lung disease?
Knowledge-focused Not yet recruitingThis study looks at whether environmental toxins, drugs, and workplace exposures play a role in causing pulmonary arterial hypertension (PAH), a rare and serious lung condition. Researchers will compare 150 newly diagnosed patients with PAH to those with another form of pulmonary…
Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Could new hormone creams protect menopausal Women's hearts?
Knowledge-focused Not yet recruitingThis large registry study will follow over 2,700 postmenopausal women aged 45-75 who use newer forms of hormone replacement therapy (creams, gels, sprays). The goal is to see if these modern delivery methods lower the risk of heart attacks, strokes, and other cardiovascular event…
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New study to uncover hidden risks for heart patients over 80 in the ICU
Knowledge-focused Not yet recruitingThis study will follow 4,000 intensive care patients aged 80 and older to see how chronic and acute heart conditions impact their survival, daily function, and quality of life. Researchers will use simple tests to measure frailty and independence. The goal is to help doctors bett…
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Small study explores real-world switch to riociguat for tough PAH cases
Knowledge-focused Not yet recruitingThis observational study will review medical records of 15 adults with pulmonary arterial hypertension (PAH) who switched from one medication (a PDE5 inhibitor) to riociguat while already on triple therapy. The goal is to see if this switch improves exercise ability, symptoms, an…
Sponsor: Caio Júlio César dos Santos Fernandes • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
500 beijing seniors to be tracked for urinary health and disease links
Knowledge-focused Not yet recruitingThis study will follow 500 Beijing residents aged 60 and older to see how urinary function (like bladder and kidney health) relates to the development of multiple chronic conditions such as diabetes, heart disease, and Alzheimer's. Participants will have regular health checks, bl…
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Scientists hunt for genes behind rare lung complication in liver bypass patients
Knowledge-focused Not yet recruitingThis study aims to find genetic variants that may explain why some people with a rare liver bypass condition (congenital portosystemic shunt) develop a serious lung complication called portopulmonary hypertension. Researchers will analyze blood samples from 120 patients and their…
Sponsor: Prof. Valérie Mc Lin • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Heart clinic mental health crisis revealed?
Knowledge-focused Not yet recruitingThis study will ask 380 heart patients and healthcare workers at Assiut University Heart Hospital to fill out questionnaires about depression, anxiety, stress, and burnout. No treatments or changes are given—the goal is simply to find out how common these mental health problems a…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New registry aims to improve survival in pulmonary hypertension emergencies
Knowledge-focused Not yet recruitingThis study will follow 200 adults with pulmonary arterial hypertension who experience a sudden worsening of right heart failure. Researchers will collect medical data to see how many survive or need a lung transplant within 3 and 12 months. The goal is to identify better ways to …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Study aims to map how patients and caregivers find information about pulmonary hypertension
Knowledge-focused Not yet recruitingThis study uses a short questionnaire to learn where patients with pulmonary hypertension and their caregivers search for health information, what topics they look for, how satisfied they are, and which sources they trust most. Researchers will enroll 100 adults in Brazil. The go…
Sponsor: University of Sao Paulo General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
AI stethoscope could spot hidden heart disease early
Knowledge-focused Not yet recruitingThis study will test whether an artificial intelligence (AI) system can detect pulmonary hypertension and other heart diseases using a smart stethoscope. Researchers will collect heart sound and ECG recordings from 1,000 adults already scheduled for routine echocardiography. The …
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Sleep troubles may worsen heart disease in seniors, new study warns
Knowledge-focused Not yet recruitingThis study looks at how sleep disorders and problems with the body's automatic functions (like heart rate control) are linked in elderly people with heart disease. Researchers will study 210 patients aged 65 and older to find out how common sleep issues are and how they affect he…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC